JEANNINE THOMAS: Open Payments
NPI 1962737957 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 31 payments from 9 companies in 2025. Trend: 2023 $3,837 · 2024 $3,263 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $517 |
| Novartis Pharmaceuticals Corporation | 18 | $177 |
| Eisai Inc. | 2 | $30 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
| Medtronic, Inc. | 1 | $15 |
| TG Therapeutics, Inc. | 1 | $14 |
Products named: INFINITY, KESIMPTA, FREESTYLE LIBRE 3, Leqembi, PURIFIED CORTROPHIN GEL, NURTEC ODT, AMYVID, UBRELVY.
Industry payments across TX — which companies pay providers there.
